Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cancer Journal (Sudbury, Mass.)
|
October 18, 2016
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients
Daniel C Danila, Aliaksandra Samoila, Chintan Patel, et al.
The Journal of Applied Laboratory Medicine
|
July 1, 2020
Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood
Aliaksandra Samoila, Jose Sosa, Jessica Padilla, et al.
British Journal of Cancer
|
February 10, 2017
Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR<sup>+</sup>, HER2<sup>-</sup> advanced breast cancer: results from BOLERO-2
Mary Ellen Moynahan, David Chen, Wei He, et al.
JAMA Oncology
|
August 18, 2016
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
Sarat Chandarlapaty, David Chen, Wei He, et al.
Oncotarget
|
December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
Parisa Momtaz, James J Harding, Charlotte Ariyan, et al.
JCO Precision Oncology
|
April 10, 2018
Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with <i>EWSR1</i> fusion-positive sarcomas
Neerav N Shukla, Juber A Patel, Heather Magnan, et al.
JCO Precision Oncology
|
July 12, 2021
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study
Lillian M Smyth, Jonathan B Reichel, Jiabin Tang, et al.
Nature Medicine
|
August 14, 2019
Resistance to TRK inhibition mediated by convergent MAPK pathway activation
Emiliano Cocco, Alison M Schram, Amanda Kulick, et al.
Nature
|
January 25, 2019
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra M Miller, Ronak H Shah, Elena I Pentsova, et al.
Cancer Discovery
|
December 7, 2019
Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i>-Mutant Metastatic Breast Cancer
Lillian M Smyth, Sarina A Piha-Paul, Helen H Won, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cancer Journal (Sudbury, Mass.)
|
October 18, 2016
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients
Daniel C Danila, Aliaksandra Samoila, Chintan Patel, et al.
The Journal of Applied Laboratory Medicine
|
July 1, 2020
Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood
Aliaksandra Samoila, Jose Sosa, Jessica Padilla, et al.
British Journal of Cancer
|
February 10, 2017
Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR<sup>+</sup>, HER2<sup>-</sup> advanced breast cancer: results from BOLERO-2
Mary Ellen Moynahan, David Chen, Wei He, et al.
JAMA Oncology
|
August 18, 2016
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
Sarat Chandarlapaty, David Chen, Wei He, et al.
Oncotarget
|
December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
Parisa Momtaz, James J Harding, Charlotte Ariyan, et al.
JCO Precision Oncology
|
April 10, 2018
Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with <i>EWSR1</i> fusion-positive sarcomas
Neerav N Shukla, Juber A Patel, Heather Magnan, et al.
JCO Precision Oncology
|
July 12, 2021
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study
Lillian M Smyth, Jonathan B Reichel, Jiabin Tang, et al.
Nature Medicine
|
August 14, 2019
Resistance to TRK inhibition mediated by convergent MAPK pathway activation
Emiliano Cocco, Alison M Schram, Amanda Kulick, et al.
Nature
|
January 25, 2019
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra M Miller, Ronak H Shah, Elena I Pentsova, et al.
Cancer Discovery
|
December 7, 2019
Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i>-Mutant Metastatic Breast Cancer
Lillian M Smyth, Sarina A Piha-Paul, Helen H Won, et al.
Page
of 2